Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 117.6B | 106.4B | 100.9B | 59.4B |
Cost of revenue | 94.9B | 77.0B | 73.0B | 40.9B |
Gross profit | 22.7B | 29.4B | 27.9B | 18.5B |
Operating expense | ||||
Research & development | 667.5M | 778.2M | 927.1M | 661.2M |
Selling general and admin | 4.6B | 6.6B | 6.2B | 5.0B |
Other operating expenses | 265.5M | 804.5M | 788.5M | 937.0M |
Operating income | 8.7B | 8.9B | 8.4B | 6.3B |
Non operating interest income | ||||
Income | 1.1B | 1.1B | 669.0M | 478.3M |
Expense | 2.7B | 2.6B | 2.5B | 1.2B |
Other income expense | — | — | — | — |
Pretax income | 5.7B | 8.0B | 6.5B | 6.2B |
Tax provision | 1.1B | 1.7B | 2.2B | 1.5B |
Net income | 4.6B | 6.3B | 4.3B | 4.7B |
Basic EPS | — | 183 | 127 | 137 |
Diluted EPS | — | 183 | 127 | 137 |
Basic average shares | — | 34.0M | 34.2M | 34.2M |
Diluted average shares | — | 34.0M | 34.2M | 34.2M |
EBITDA | 15.6B | 11.8B | 11.0B | 8.0B |
Net income from continuing op. | 4.6B | 6.3B | 4.3B | 4.7B |
Minority interests | -215.2M | -83.4M | 16.1M | -16.6M |
Preferred stock dividends | — | — | — | — |